← back to database
Hartmann Capital is the institutional gateway to early-stage frontier tech, investing through its flagship Hartmann Ventures fund across AI, AR/BCI (brain-computer interfaces), and longevity biotech, alongside a separate Digital Assets Fund. Portfolio includes Paradromics, Neurable, Orchid, iOrganBio, and ShapesXR.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Felix HartmannManaging Partner
How to reach them
Notable investments
Paradromics, Neurable, Orchid, ShapesXR, Foundational Bio, iOrganBio